220 related articles for article (PubMed ID: 27059620)
21. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
[TBL] [Abstract][Full Text] [Related]
22. Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.
Nguyen KL; Park EA; Yoshida T; Hu P; Finn JP
J Cardiovasc Magn Reson; 2017 Dec; 19(1):106. PubMed ID: 29284494
[TBL] [Abstract][Full Text] [Related]
23. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
[TBL] [Abstract][Full Text] [Related]
24. Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent.
Bashir MR; Jaffe TA; Brennan TV; Patel UD; Ellis MJ
Transplantation; 2013 Jul; 96(1):91-6. PubMed ID: 23680931
[TBL] [Abstract][Full Text] [Related]
25. MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage.
Larsson EM; Sundén P; Olsson CG; Debatin J; Duerinckx AJ; Baum R; Hahn D; Ebner F
AJR Am J Roentgenol; 2003 Jan; 180(1):227-32. PubMed ID: 12490510
[TBL] [Abstract][Full Text] [Related]
26. Ferumoxytol MR Angiography versus Duplex US for Vascular Mapping before Arteriovenous Fistula Surgery for Hemodialysis.
Stoumpos S; Tan A; Hall Barrientos P; Stevenson K; Thomson PC; Kasthuri R; Radjenovic A; Kingsmore DB; Roditi G; Mark PB
Radiology; 2020 Oct; 297(1):214-222. PubMed ID: 32692301
[TBL] [Abstract][Full Text] [Related]
27. Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography.
Stabi KL; Bendz LM
Ann Pharmacother; 2011 Dec; 45(12):1571-5. PubMed ID: 22045905
[TBL] [Abstract][Full Text] [Related]
28. A three-dimensional gadolinium-enhanced MR venography technique for imaging central veins.
Thornton MJ; Ryan R; Varghese JC; Farrell MA; Lucey B; Lee MJ
AJR Am J Roentgenol; 1999 Oct; 173(4):999-1003. PubMed ID: 10511166
[TBL] [Abstract][Full Text] [Related]
29. Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment.
Yoshida T; Nguyen KL; Shahrouki P; Quinones-Baldrich WJ; Lawrence PF; Finn JP
J Vasc Surg; 2020 May; 71(5):1674-1684. PubMed ID: 31734117
[TBL] [Abstract][Full Text] [Related]
30. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.
Li W; Salanitri J; Tutton S; Dunkle EE; Schneider JR; Caprini JA; Pierchala LN; Jacobs PM; Edelman RR
Radiology; 2007 Mar; 242(3):873-81. PubMed ID: 17325072
[TBL] [Abstract][Full Text] [Related]
31. High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
Iv M; Choudhri O; Dodd RL; Vasanawala SS; Alley MT; Moseley M; Holdsworth SJ; Grant G; Cheshier S; Yeom KW
J Neurosurg Pediatr; 2018 Sep; 22(3):251-260. PubMed ID: 29882734
[TBL] [Abstract][Full Text] [Related]
32. Incidental ferumoxytol artifacts in clinical brain MR imaging.
Bowser BA; Campeau NG; Carr CM; Diehn FE; McDonald JS; Miller GM; Kaufmann TJ
Neuroradiology; 2016 Nov; 58(11):1087-1091. PubMed ID: 27704163
[TBL] [Abstract][Full Text] [Related]
33. Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
Toth GB; Varallyay CG; Horvath A; Bashir MR; Choyke PL; Daldrup-Link HE; Dosa E; Finn JP; Gahramanov S; Harisinghani M; Macdougall I; Neuwelt A; Vasanawala SS; Ambady P; Barajas R; Cetas JS; Ciporen J; DeLoughery TJ; Doolittle ND; Fu R; Grinstead J; Guimaraes AR; Hamilton BE; Li X; McConnell HL; Muldoon LL; Nesbit G; Netto JP; Petterson D; Rooney WD; Schwartz D; Szidonya L; Neuwelt EA
Kidney Int; 2017 Jul; 92(1):47-66. PubMed ID: 28434822
[TBL] [Abstract][Full Text] [Related]
34. Pictorial review on abdominal applications of ferumoxytol in MR imaging.
Kordbacheh H; Baliyan V; Parakh A; Wojtkiewicz GR; Hedgire S; Harisinghani MG
Abdom Radiol (NY); 2019 Oct; 44(10):3273-3284. PubMed ID: 31378828
[TBL] [Abstract][Full Text] [Related]
35. MR Imaging of the Mesenteric Vasculature.
Collins JD
Radiol Clin North Am; 2020 Jul; 58(4):797-813. PubMed ID: 32471545
[TBL] [Abstract][Full Text] [Related]
36. MRI diagnosis of dural sinus - Cortical venous thrombosis: Immediate post-contrast 3D GRE T1-weighted imaging versus unenhanced MR venography and conventional MR sequences.
Sari S; Verim S; Hamcan S; Battal B; Akgun V; Akgun H; Celikkanat S; Tasar M
Clin Neurol Neurosurg; 2015 Jul; 134():44-54. PubMed ID: 25938564
[TBL] [Abstract][Full Text] [Related]
37. Vascular Imaging With Ferumoxytol as a Contrast Agent.
Hope MD; Hope TA; Zhu C; Faraji F; Haraldsson H; Ordovas KG; Saloner D
AJR Am J Roentgenol; 2015 Sep; 205(3):W366-73. PubMed ID: 26102308
[TBL] [Abstract][Full Text] [Related]
38. Ferumoxytol-enhanced MRI in the peripheral vasculature.
Lehrman ED; Plotnik AN; Hope T; Saloner D
Clin Radiol; 2019 Jan; 74(1):37-50. PubMed ID: 29731126
[TBL] [Abstract][Full Text] [Related]
39. Ferumoxytol-enhanced magnetic resonance angiography provides comparable vascular conspicuity to CT angiography in dogs with intrahepatic portosystemic shunts.
Wilson S; Culp WTN; Wisner ER; Cissell DD; Finn JP; Zwingenberger AL
Vet Radiol Ultrasound; 2021 Jul; 62(4):463-470. PubMed ID: 33634935
[TBL] [Abstract][Full Text] [Related]
40. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
